Advisornet Financial’s Ionis Pharmaceuticals IONS Stock Holding History

Advisornet Financial’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$71.7K	Buy	904 +331	+58%	+$24.9K	﹤0.01%	997
2026 Q1	$43K	Sell	573 -40	-7%	-$3.16K	﹤0.01%	1098
2025 Q4	$48.5K	Buy	613 +144	+31%	+$10.8K	﹤0.01%	1058
2025 Q3	$30.7K	Buy	469 +41	+10%	+$2K	﹤0.01%	1178
2025 Q2	$16.9K	Buy	428 +425	+14,167%	+$13.9K	﹤0.01%	1332
2025 Q1	$91	Buy	3 +2	+200%	+$65	﹤0.01%	2115
2024 Q4	$35	Hold	1	–	–	﹤0.01%	1953
2024 Q3	$40	Buy	+1	New	+$47	﹤0.01%	2171
2022 Q2	–	Sell	-29	Closed	-$1K	–	2004
2022 Q1	$1K	Hold	29	–	–	﹤0.01%	1894
2021 Q4	$1K	Hold	29	–	–	﹤0.01%	1932
2021 Q3	$1K	Hold	29	–	–	﹤0.01%	1815
2021 Q2	$1K	Hold	29	–	–	﹤0.01%	1745
2021 Q1	$1K	Hold	29	–	–	﹤0.01%	1696
2020 Q4	$2K	Hold	29	–	–	﹤0.01%	1545
2020 Q3	$1K	Hold	29	–	–	﹤0.01%	1643
2020 Q2	$2K	Hold	29	–	–	﹤0.01%	1603
2020 Q1	$1K	Hold	29	–	–	﹤0.01%	1674
2019 Q4	$2K	Sell	29 -70	-71%	-$4.17K	﹤0.01%	1685
2019 Q3	$6K	Buy	99 +70	+241%	+$4.56K	﹤0.01%	1497
2019 Q2	$2K	Hold	29	–	–	﹤0.01%	1525
2019 Q1	$2K	Hold	29	–	–	﹤0.01%	1422
2018 Q4	$2K	Buy	+29	New	+$1.48K	﹤0.01%	1345

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Advisornet Financial's IONS Position: Q2 2026 in Review

Advisornet Financial increased its Ionis Pharmaceuticals (IONS) stake by 58% in Q2 2026, buying an estimated $24.9K and bringing the position to 904 shares worth $71.7K. The position accounts for ﹤0.01% of the portfolio, ranked #997.

Advisornet Financial first reported a position in IONS in Q4 2018 and has held it in 22 quarters since. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

Advisornet Financial held 904 shares of Ionis Pharmaceuticals worth $71.7K as of Q2 2026.
Advisornet Financial bought 331 Ionis Pharmaceuticals shares in Q2 2026, an estimated $24.9K.
Ionis Pharmaceuticals made up ﹤0.01% of Advisornet Financial's portfolio in Q2 2026, its #997 holding.
Advisornet Financial first reported a position in Ionis Pharmaceuticals in Q4 2018 and has held it in 22 quarters since.
515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.